Bioinformatics analysis revealed lower levels of TrxR3 and SELO expression in NAFLD, while SELM, DIO1, GPx2, and GPx3 were highly expressed in NAFLD compared with the healthy group [118]. The gene discussed is GPX2; the disease is metabolic dysfunction-associated steatotic liver disease.